Today's Date: February 21, 2024
Californians for Financial Education Campaign Applauds New Legislation Requiring Personal Finance Education for All Students   •   Why is skin disease often misdiagnosed and untreated in Black patients?   •   Pinterest to Participate at the Morgan Stanley Technology, Media & Telecom Conference   •   Avangrid Fourth Quarter & Full Year 2023 Financial Results Available on Company’s Website   •   Energy Recovery Announces CFO Transition   •   Perdoceo Education Corporation Reports Fourth Quarter and Full Year 2023 Results   •   Annual Arts in Hong Kong Event to Kick-off in March Offering a Variety of Arts Experiences Along Iconic Victoria Harbour   •   Ziegler Prices Financing For The United Methodist Retirement Homes   •   National Geographic Documentary Films Acquires Sundance Film Festival Award-Winner SUGARCANE   •   Independent Women's Voice Testifies Before Alabama Legislature in Support of HB 111 & SB 92 to Establish Legal Definitions o   •   PG&E Identifies More than 20 Climate-Tech Solutions Aimed at Achieving a Clean Energy Future   •   Lake Babine Nation and Canada sign agreement to support community vision for governance, capacity development, and infrastructur   •   Orbia Announces Fourth Quarter and Full-Year 2023 Financial Results   •   Sallie Mae CFO to Speak at 2024 RBC Capital Markets Global Financial Institutions Conference   •   Government of Canada and Mushkegowuk Council successfully complete feasibility assessment and take a major step toward officiall   •   Green Plains to Participate in Bank of America 2024 Global Agriculture and Materials Conference   •   Black Health Matters Winter Health Summit and Expo Returns to Atlanta   •   A City Boy Discovers Nature's Playground: New Book Inspires Children to Connect with the Great Outdoors   •   Helping Canadian creative businesses and organizations achieve financial success on the world stage   •   Semrush Holdings, Inc. to Participate in Upcoming Investor Conferences
Bookmark and Share

Individuals and Entities who Consumed and/or Paid for Valsartan or Valsartan‐Containing Drugs, a Class Action Lawsuit Coul

Individuals and Entities who Consumed and/or Paid for Valsartan or Valsartan‐Containing Drugs, a Class Action Lawsuit Could Affect Your Rights

PR Newswire

CAMDEN, N.J., Dec. 4, 2023 /PRNewswire/ -- The following notice is being issued by the Court approved Class Administrator and has been authorized by the U.S. District Court for the District of New Jersey, in In re: Valsartan, Losartan, and Irbesartan Products Liability Litigation, Case No. 1:19-md-02875-RBK-SAK.

The Lawsuit alleges that Defendants (a complete list of these Defendants is available at the Case Website, www.ValsartanMedicationLawsuit.com) violated state laws by manufacturing, distributing, producing, and/or selling Valsartan or Valsartan-Containing Drugs ("VCDs") that were contaminated with probable human carcinogens in the form of nitrosamines, N-nitrosodimethylamine ("NDMA") and N-nitrosodiethylamine ("NDEA"). The Defendants have denied any wrongdoing, have denied that the amounts of NDMA and NDEA in the Valsartan and VCDs at issue were or could be carcinogenic, and have asserted various legal and factual defenses to the claims asserted on behalf of the Classes.

The Court has not decided whether the Defendants did anything wrong or whether the Plaintiffs' claims have merit. However, the Court has certified a Consumer Economic Loss Class, Medical Monitoring Class, and Third Party Payor ("TPP") Class and various Subclasses of which you may be a member unless you exclude yourself from the Lawsuit. If you qualify as a member of a Class, you have the right to participate as a class member or to opt out. Certain exceptions apply.

The Lawsuit is ongoing. You may visit the Case Website to register for case updates regarding the Lawsuit and any potential recovery or benefits to class members. This will help us contact you in the event of any future settlement or judgment. This Notice does not include or affect any personal injury claims.

Who is Included?

The Classes are generally defined as:

Consumer Economic Loss Class: All individuals in the United States and its territories and possessions who, since at least January 1, 2012 through the date of final recall as of November 10, 2021, paid any amount of money for a valsartan‐containing drug (intended for personal or household use) that was manufactured by any Active Pharmaceutical Ingredient or Finished Dose Defendant, and distributed or sold in the United States by any Defendant.

Medical Monitoring Classes: Individuals residing in the United States and its territories and possessions (except Mississippi, New Hampshire, North Carolina, and North Dakota) who consumed a sufficiently high Lifetime Cumulative Threshold of NDMA or NDEA, in generic VCDs manufactured by any Active Pharmaceutical Ingredient or Finished Dose Defendant, and marketed in the United States and its territories and possessions, at least since January 1, 2012.

Third Party Payer Class: All Third Party Payors that, from at least January 1, 2012 through the date of final recall as of November 10, 2021, paid any amount of money in the United States and its territories and possessions for a VCD that was manufactured by any Active Pharmaceutical Ingredient or Finished Dose Defendant, and distributed or sold in the United States by any Active Pharmaceutical Ingredient, Finished Dose, or Wholesaler Defendant.

Detailed information regarding the exact Classes and Subclasses are viewable on the Case Website www.ValsartanMedicationLawsuit.com.

What Are My Rights And Options?

Do Nothing: If you do nothing, you will remain a part of the Class and Lawsuit and you will be bound by any future judgment(s) of the Court.

Opt-Out: All individuals and entities that satisfy a Class definition will be automatically included in the Class unless they choose to opt-out from the Class and Lawsuit entirely. To opt-out, you must submit an exclusion request to the Class Administrator by email (info@ValsartanMedicationLawsuit.com) or mail to Valsartan Class Administrator, ATTN: Exclusion Request, PO Box 3376, Baton Rouge, LA 70821, postmarked or emailed and received no later than January 31, 2024. This date may change, check the Case Website for updates. This is the only option that allows you to pursue your own claims against one or more Defendants for the legal claims made in the Lawsuit. Choosing this option means you will not be bound by any future determinations made in the Lawsuit; however, you will also not be eligible for any payments or other benefits, if any, that are awarded to the Class by the Court.

Complete details about how to opt-out from the Class and Lawsuit are available on the Case Website www.ValsartanMedicationLawsuit.com.

Do I have a lawyer in this case? Yes, if you do not exclude yourself by opting out. The Court has appointed Ruben Honik of Honik LLC, Conlee Whiteley of Kanner & Whiteley, LLC, and John R. Davis of Slack Davis Sanger, LLP to represent the Consumer Economic Loss Class. Rachel Geman of Lieff Cabraser Heimann & Bernstein and Nicholas Migliaccio of Migliaccio & Rathod LLP have been appointed to represent the Medical Monitoring Class. Jorge Mestre of Rivero Mestre LLP and Gregory Hansel of Preti Flaherty Beliveau & Pachios Chartered LLP to represent the TPP Class.

Where can I get more information? This is only a summary of the Lawsuit, your legal rights and options. If you have questions, want to view the detailed notice or other documents, or register to receive updates regarding this Lawsuit, visit www.ValsartanMedicationLawsuit.com. You may also call 1-866-875-9644.

Please do not write or call the Court or the Clerk's Office for information.

Cision View original content:https://www.prnewswire.com/news-releases/individuals-and-entities-who-consumed-andor-paid-for-valsartan-or-valsartancontaining-drugs-a-class-action-lawsuit-could-affect-your-rights-302004019.html

SOURCE Valsartan Class Administrator



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News